The Sentinel surveillance system could grow to study drug safety during pregnancy and other health outcomes as part of the prescription drug user fee reauthorization.
The US Food and Drug Administration has proposed including pregnancy safety as a health outcome of interest to be studied using Sentinel, the agency’s safety system that uses insurance claims, electronic medical records and other data to spot potential signals. In recently released
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?